The Trump administration decided to put the pilot on hold until at least 2027.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
NEW YORK (AP) — The Trump administration will require all 50 states to explain their plans to revalidate some of their ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
3don MSN
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...
The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...
Dr. Mehmet Oz announced an initiative, requiring all 50 states to audit their Medicaid provider networks in a move marking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results